Cortexyme (CRTX) –
-
Form 8-K Cortexyme, Inc. For: Aug 01
-
Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022
-
Cortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588
-
Cortexyme (CRTX) Announces Resignation of EVP of Research and Development
-
Form 8-K Cortexyme, Inc. For: Jul 20
-
Form SC 13G/A Cortexyme, Inc. Filed by: Capital World Investors
-
Form 4 Cortexyme, Inc. For: Jun 29 Filed by: Monohon Ted
-
Cortexyme Announces Preclinical Data Demonstrating Efficacy of COR803 for the Treatment of Coronavirus Infections
-
Cortexyme Appoints June Bray to its Board of Directors
-
Form 4 Cortexyme, Inc. For: Jun 09 Filed by: Bray June
-
Form 3 Cortexyme, Inc. For: Jun 09 Filed by: Bray June
-
Form 4 Cortexyme, Inc. For: Jun 08 Filed by: Senner Christopher J.
-
Form 4 Cortexyme, Inc. For: Jun 08 Filed by: RYAN UNA S
-
Form 4 Cortexyme, Inc. For: Jun 08 Filed by: Lamond David
-
Form 4 Cortexyme, Inc. For: Jun 08 Filed by: McLoughlin Margaret
-
Form 4 Cortexyme, Inc. For: Jun 06 Filed by: Monohon Ted
-
Form 4 Cortexyme, Inc. For: Jun 06 Filed by: Holsinger Leslie
-
Form 4 Cortexyme, Inc. For: Jun 06 Filed by: McDowell Caryn Gordon
-
Form 4/A Cortexyme, Inc. For: May 19 Filed by: Smith Karen L.
-
Form 4/A Cortexyme, Inc. For: May 19 Filed by: Hannah Brendan
-
Form 4/A Cortexyme, Inc. For: May 19 Filed by: Thye Dirk
-
Form DEFA14A Cortexyme, Inc.
-
Form 4 Cortexyme, Inc. For: May 19 Filed by: Thye Dirk
-
Form 3 Cortexyme, Inc. For: May 19 Filed by: Thye Dirk
-
Form 4 Cortexyme, Inc. For: May 19 Filed by: Smith Karen L.
-
Form 3 Cortexyme, Inc. For: May 19 Filed by: Smith Karen L.
-
Form 4 Cortexyme, Inc. For: May 19 Filed by: Low Philip S
-
Form 3 Cortexyme, Inc. For: May 19 Filed by: Low Philip S
-
Form 4 Cortexyme, Inc. For: May 19 Filed by: Lamond David
-
Form 4 Cortexyme, Inc. For: May 19 Filed by: Hannah Brendan
-
Form 3 Cortexyme, Inc. For: May 19 Filed by: Hannah Brendan
-
Form S-8 Cortexyme, Inc.
-
Form 8-K Cortexyme, Inc. For: May 19
-
Cortexyme (CRTX) Appoints Philip Low to Its Board
-
Cortexyme Appoints Dr. Philip Low to Its Board of Directors
-
Cortexyme Successfully Completes Acquisition of Novosteo
-
Form 424B5 Cortexyme, Inc.
-
Form EFFECT Cortexyme, Inc.
-
Form POS EX Cortexyme, Inc.
-
Form 8-K Cortexyme, Inc. For: May 07
-
Cortexyme to Participate at 4th International Conference on Porphyromonas gingivalis and Related Species in Oral and Systemic Diseases
-
Cortexyme Inc. (CRTX) PT Lowered to $3.50 at Credit Suisse
-
Form 10-Q Cortexyme, Inc. For: Mar 31
-
Form 8-K Cortexyme, Inc. For: May 09
-
Cortexyme (CRTX) to Acquire Novosteo
-
Cortexyme Announces Agreement to Acquire Novosteo
-
Bragar Eagel & Squire, P.C. Is Investigating Agrify, CareDx, Medallion, and Cortexyme and Encourages Investors to Contact the Firm
-
Form 8-K Cortexyme, Inc. For: Apr 26
-
Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Cortexyme, and Corcept and Encourages Investors to Contact the Firm
-
Form DEFA14A Cortexyme, Inc.
Back to CRTX Stock Lookup